UNVERIFIEDSingle SourceOpinion: CMS shouldn’t be paying for higher-than-necessary doses of cancer drugsStat News|3/3/2026
UNVERIFIEDSingle SourceSTAT+: CMS wants more drugmakers to join Medicaid ‘most-favored nations’ pilotStat News|3/3/2026
UNVERIFIEDSingle SourceSTAT+: FDA rejection is a reality check on agency rhetoric Stat News|2/26/2026
UNVERIFIEDSingle SourceSTAT+: Drugmakers lay out their legal arguments against Trump’s drug pricing experimentsStat News|2/24/2026
UNVERIFIEDSingle SourceSTAT+: Novo’s next-gen obesity drug stumbles in Lilly comparison studyStat News|2/23/2026
UNVERIFIEDSingle SourceSTAT+: Element Biosciences launches table-top sequencer capable of $100 genomeStat News|2/20/2026
UNVERIFIEDSingle SourceSTAT+: The unusual Prasad missive in the FDA’s rejection of the Moderna flu shot applicationStat News|2/11/2026
UNVERIFIEDSingle SourceSTAT+: Evommune reports positive mid-stage data for eczema drugStat News|2/10/2026
UNVERIFIEDSingle SourceSTAT+: The risk score shuffle, and TrumpRx’s not-so-great dealsStat News|2/9/2026
UNVERIFIEDSingle SourceSTAT+: TrumpRx claims to offer the lowest prices. But many drugs have cheaper genericsStat News|2/6/2026
UNVERIFIEDSingle SourceSTAT+: White House looks for more drug pricing deals to add to TrumpRxStat News|2/6/2026
UNVERIFIEDSingle SourceWhat to know about TrumpRx, the Trump administration’s prescription drug platformStat News|2/5/2026
UNVERIFIEDSingle SourceSTAT+: Novo and Lilly both see price cuts as helpful for long-term gainStat News|2/5/2026
UNVERIFIEDSingle SourceSTAT+: Launch of Wegovy pill looks to be going strong so farStat News|1/26/2026